Related Experiment Video

Updated: Jun 3, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Panniculitis in a patient with dermatomyositis

Mariana Arias1, María Inés Hernández, Lais Gomes Barbosa Cunha

  • 1Hospital General de Agudos Dr. Cosme Argerich, Buenos Aires, Argentina. mariana_arias77@yahoo.com.ar

Anais Brasileiros De Dermatologia
|March 26, 2011
PubMed

Insights

Panniculitis, an uncommon finding in dermatomyositis, can appear before other symptoms. This case highlights steroid treatment effectively resolving skin lesions in a patient with dermatomyositis and panniculitis.

Area of Science:

  • Rheumatology and Dermatology
  • Clinical Case Study

Background:

  • Panniculitis is infrequently observed in patients diagnosed with dermatomyositis.
  • Cutaneous and muscular symptoms of dermatomyositis can be preceded by panniculitis.
  • Simultaneous improvement of myositis and panniculitis is noted during therapeutic interventions.

Observation:

  • A 30-year-old female presented with panniculitis two months after the onset of muscle and skin symptoms.
  • Clinical examination and histopathology confirmed panniculitis.
  • The patient's presentation was consistent with a diagnosis of dermatomyositis.

Findings:

  • The panniculitis preceded the definitive diagnosis of dermatomyositis by two months.
  • Dermatomyositis diagnosis was supported by concurrent muscle and cutaneous manifestations.
  • Skin lesions associated with panniculitis showed regression after corticosteroid therapy.

Implications:

  • Panniculitis may serve as an early indicator of underlying dermatomyositis.
  • Prompt diagnosis and treatment of dermatomyositis, including its panniculitic manifestation, are crucial.
  • Corticosteroid therapy appears effective in managing panniculitis in the context of dermatomyositis.

More Related Videos

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...